Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Argus Health
US Department of Justice
Boehringer Ingelheim
Daiichi Sankyo

Generated: December 16, 2017

DrugPatentWatch Database Preview

Details for Patent: 4,284,786

« Back to Dashboard

Summary for Patent: 4,284,786

Title: 5-Methylisoxazole-4-carboxylic-(4-trifluoromethyl)-anilide
Abstract:5-Methylisoxazole-4-carboxylic acid-(4-trifluoromethyl)-anilide and a process for its preparation is described. The compound has an antirheumatic, antiphlogistic, antipyretic and analgesic action, and can be used for the treatment of multiple sclerosis.
Inventor(s): Kammerer; Friedrich-Johannes (Hochheim am Main, DE), Schleyerbach; Rudolf (Hofheim am Taunus, DE)
Assignee: Hoechst Aktiengesellschaft (Frankfurt am Main, DE)
Application Number:06/103,551
Patent Claim Types:
see list of patent claims

No matches for this query

Foreign Priority and PCT Information for Patent: 4,284,786

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany2854439Dec 16, 1978

International Patent Family for Patent: 4,284,786

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina222680► Subscribe
Argentina226894► Subscribe
Austria1067► Subscribe
Australia529341► Subscribe
Australia5385379► Subscribe
Bulgaria60764► Subscribe
Canada1129867► Subscribe
Germany2854439► Subscribe
Germany2962929► Subscribe
Denmark149886► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Chinese Patent Office
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: